SE9004010D0 - Viralt medel - Google Patents

Viralt medel

Info

Publication number
SE9004010D0
SE9004010D0 SE9004010A SE9004010A SE9004010D0 SE 9004010 D0 SE9004010 D0 SE 9004010D0 SE 9004010 A SE9004010 A SE 9004010A SE 9004010 A SE9004010 A SE 9004010A SE 9004010 D0 SE9004010 D0 SE 9004010D0
Authority
SE
Sweden
Prior art keywords
expression vectors
dna sequences
relates
viral polypeptide
viral medicine
Prior art date
Application number
SE9004010A
Other languages
English (en)
Other versions
SE9004010L (sv
SE9004010A (sv
Inventor
P E Highfield
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898928562A external-priority patent/GB8928562D0/en
Priority claimed from GB909004414A external-priority patent/GB9004414D0/en
Priority claimed from GB909004814A external-priority patent/GB9004814D0/en
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of SE9004010D0 publication Critical patent/SE9004010D0/sv
Publication of SE9004010L publication Critical patent/SE9004010L/sv
Publication of SE9004010A publication Critical patent/SE9004010A/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
    • C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
    • C07K16/109—Hepatitis C virus; Hepatitis G virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/826—Viruses
SE9004010A 1989-12-18 1990-12-17 Viralt medel SE9004010A (sv)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB898928562A GB8928562D0 (en) 1989-12-18 1989-12-18 Viral agent
GB909004414A GB9004414D0 (en) 1990-02-27 1990-02-27 Viral agent
GB909004814A GB9004814D0 (en) 1990-03-03 1990-03-03 Viral agent

Publications (3)

Publication Number Publication Date
SE9004010D0 true SE9004010D0 (sv) 1990-12-17
SE9004010L SE9004010L (sv) 1991-06-19
SE9004010A SE9004010A (sv) 1991-06-19

Family

ID=27264852

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9004010A SE9004010A (sv) 1989-12-18 1990-12-17 Viralt medel

Country Status (24)

Country Link
US (1) US6210675B1 (sv)
JP (1) JPH06107687A (sv)
AR (1) AR243239A1 (sv)
AT (1) AT400724B (sv)
AU (1) AU642942B2 (sv)
BE (1) BE1005485A5 (sv)
BR (1) BR9006422A (sv)
CA (1) CA2032381C (sv)
CH (1) CH684594A5 (sv)
DE (1) DE4040339C2 (sv)
DK (1) DK298190A (sv)
ES (1) ES2029171A6 (sv)
FI (1) FI906208A (sv)
FR (1) FR2655990A1 (sv)
GB (1) GB2239245B (sv)
GR (1) GR1001261B (sv)
HU (1) HUT56883A (sv)
IE (1) IE65172B1 (sv)
IT (1) IT1242183B (sv)
LU (1) LU87861A1 (sv)
NL (1) NL9002779A (sv)
NO (1) NO905438L (sv)
NZ (1) NZ236491A (sv)
SE (1) SE9004010A (sv)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US5698390A (en) * 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US6861212B1 (en) 1987-11-18 2005-03-01 Chiron Corporation NANBV diagnostics and vaccines
US6027729A (en) * 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
BR9106309A (pt) * 1990-04-04 1993-04-20 Chiron Corp Combinacao de antigenos sinteticos de hepatite c viral (hcv),processo de detectar anticorpos para o virus da hepatite c e estojo para realizar teste
US5712087A (en) * 1990-04-04 1998-01-27 Chiron Corporation Immunoassays for anti-HCV antibodies employing combinations of hepatitis C virus (HCV) antigens
DE69132332T2 (de) * 1990-04-06 2000-11-30 Genelabs Tech Inc Hepatitis c-virus-epitope
JP3549201B2 (ja) * 1990-10-24 2004-08-04 中外製薬株式会社 非ａ非ｂ型肝炎特異的遺伝子の検出方法及び検出用試薬組成物
EP0485209A1 (en) * 1990-11-08 1992-05-13 Immuno Japan Inc. Non A, non B hepatitis virus related antigen, antibody detection systems, polynucleotides and polypeptides
KR920703640A (ko) * 1990-11-29 1992-12-18 테루카츄 아리마 비a비b형 간염 바이러스 항원 단백질
US6190864B1 (en) 1991-05-08 2001-02-20 Chiron Corporation HCV genomic sequences for diagnostics and therapeutics
HU227548B1 (en) * 1991-05-08 2011-08-29 Novartis Vaccines & Diagnostic Process for production of non-naturally occuring non-hcv-1 nucleic acids, forming a hybridization product, and detecting hcv genotypes
UA40572C2 (uk) * 1991-06-24 2001-08-15 Чірон Корпорейшн Поліпептид, що містить укорочену послідовність вірусу гепатиту с, ізольований епітоп, реагент для імуноаналізу на вірус гепатиту с (варіанти), спосіб виявлення наявності антитіл (варіанти)
WO1993002193A1 (es) * 1991-07-19 1993-02-04 Bartolome Nebreda Fernando Jav cDNAS DERIVADOS DEL VIRUS C DE LA HEPATITIS
DE69223562T2 (de) * 1991-08-27 1998-06-04 Hoffmann La Roche Verfahren und Reagenzien zum Nachweis von Hepatitis C
GB9203803D0 (en) * 1992-02-21 1992-04-08 Wellcome Found A recombinant polypeptide
UA39944C2 (uk) * 1992-07-07 2001-07-16 Чірон Корпорейшн Спосіб визначення ранньої сероконверсії у ссавця-хазяїна до вірусу гепатиту с і набір для використання в способі
US6153378A (en) * 1992-10-16 2000-11-28 Bionova Corporation Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
US7255997B1 (en) 1993-04-27 2007-08-14 N.V. Innogenetics S.A. Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
DE69435023T2 (de) 1993-04-27 2008-09-11 N.V. Innogenetics S.A. Sequenzen der genotype des hepatitis-c-virus sowie ihre verwendung als arzneimittel und diagnostika
AU8003894A (en) * 1993-10-29 1995-05-22 Srl Inc. Antigen peptide compound and immunoassay method
EP1076092A3 (en) 1994-10-21 2001-03-28 Innogenetics N.V. Sequences of hepatitis C virus type10 and their use as prophylactic, therapeutic and diagnostic agents
FR2775690B1 (fr) * 1998-03-09 2001-12-14 Bio Merieux Anticorps monoclonal et utilisations pour detecter des antigenes de la proteine core de vhc
US6071721A (en) * 1998-11-13 2000-06-06 Incyte Pharmaceuticals, Inc. Calcium binding protein
US7067313B1 (en) * 1999-07-14 2006-06-27 D. Collen Research Foundation Ligands for use in therapeutic compositions for the treatment of hemostasis disorders
US7829085B2 (en) * 1999-07-14 2010-11-09 Life Sciences Research Partners Vzw Methods of treating hemostasis disorders using antibodies binding the C1 domain of factor VIII
CU23244A1 (es) * 2001-07-16 2007-10-17 Ct Ingenieria Genetica Biotech Formulacion vacunal potenciada por la combinacion de un adn con un antigeno
US7196183B2 (en) 2001-08-31 2007-03-27 Innogenetics N.V. Hepatitis C virus genotype, and its use as prophylactic, therapeutic and diagnostic agent
MXPA05002641A (es) * 2002-09-09 2005-05-05 Chiron Corp Ensayo del virus de la hepatitis c.
JP4422430B2 (ja) * 2003-05-14 2010-02-24 帝國製薬株式会社 エストロゲン及び／又はプロゲストゲン含有外用貼付剤
US7785594B2 (en) * 2003-08-14 2010-08-31 Life Sciences Research Partners Vzw Factor VIII inhibitory antibodies with reduced glycosylation
US8124747B2 (en) 2003-08-29 2012-02-28 Innogenetics HCV clade and prototype sequences thereof
ES2702278T3 (es) 2012-04-01 2019-02-28 Technion Res & Dev Foundation Péptidos de inductor de metaloproteinasa de matriz extracelular (emmprin) y anticuerpos de unión
CN111867614A (zh) * 2018-01-18 2020-10-30 艾达奈特公司 抗lilrb抗体及其用途

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356164A (en) 1979-05-21 1982-10-26 Govt. of the U.S., as represented by the Secretary, Dept. of Health & Human Services Detection of non-A, non-B hepatitis associated antigen
US4464474A (en) 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
GB2108527B (en) 1981-02-11 1984-10-24 Connaught Lab Non-a non-b hepatitis virus
US4542016A (en) 1981-03-27 1985-09-17 Institut Merieux Non-a non-b hepatitis surface antigen useful for the preparation of vaccines and methods of use
JPS57198867A (en) 1981-06-02 1982-12-06 Eisai Co Ltd Non-a, non-b hepatitis related antigen and diagnostic therefor
JPS58183629A (ja) 1982-04-21 1983-10-26 Eisai Co Ltd 非ａ非ｂ型肝炎関連モノクロナ−ル抗体および診断薬
US4702909A (en) * 1982-05-05 1987-10-27 Louisiana State University A & M Non-A, non-B hepatitis antigen, antigen compositions, vaccine and diagnostic reagent
US4707439A (en) 1984-10-26 1987-11-17 The United States Of America As Represented By The Department Of Health And Human Services Screening test for reverse-transcriptase containing virus such as non-A, non-B hepatitis, NANBH
GB8431171D0 (en) 1984-12-11 1985-01-23 Technology Licence Co Ltd Monoclonal antibodies
JPS61176856A (ja) 1985-02-01 1986-08-08 Mitsubishi Chem Ind Ltd 非ａ非ｂ型肝炎抗原
US4673634A (en) 1985-03-08 1987-06-16 The United States Of America As Represented By The Department Of Health And Human Services Purified antigen from non-A, non-B hepatitis causing factor
FR2597606B1 (fr) 1986-04-16 1989-10-06 Pasteur Institut Nouveau reactif pour la detection d'hepatites virales non a non b et procede de diagnostic de telles hepatites par voie immunoenzymatique
JPS6391328A (ja) 1986-10-07 1988-04-22 Mitsubishi Kasei Corp 非ａ非ｂ型肝炎抗原
NZ222465A (en) 1986-11-07 1992-11-25 Pasteur Institut Nanb (non a, non b hepatitis viral) antigen
US5141867A (en) * 1987-02-02 1992-08-25 E. I. Du Pont De Nemours And Company Nucleotide sequence encoding a human immunodeficiency virus antigen
DE3744242A1 (de) 1987-02-20 1989-07-06 Seelig Renate Virusantigen, verfahren zu seiner gewinnung und anwendung in diagnose und therapie (impfstoff)
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
WO1989004669A1 (en) * 1987-11-18 1989-06-01 Chiron Corporation Nanbv diagnostics and vaccines
GB2212511B (en) * 1987-11-18 1992-01-22 Chiron Corp Hepatitis c virus
AU624105B2 (en) * 1987-11-18 1992-06-04 Novartis Vaccines And Diagnostics, Inc. Nanbv diagnostics and vaccines
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
AU632271B2 (en) 1988-03-30 1992-12-24 Abbott Laboratories Production of monoclonal antibodies specific for non-a, non-b hepatitis infected liver
AU3748489A (en) 1988-06-17 1990-01-12 Genelabs Incorporated Enterically transmitted non-a/non-b hepatitis viral agent
WO1990000597A1 (en) * 1988-07-06 1990-01-25 Genelabs Incorporated Post-transfusion, non-a, non-b hepatitis virus and antigens
IL91371A0 (en) 1988-08-24 1990-04-29 Us Commerce Clones or vectors bearing dna sequences of non-a and non-b hepatitis and a method for detecting these materials in blood
US5191064A (en) * 1988-09-30 1993-03-02 The Research Foundation For Microbial Diseases (Osaka University) Non-a, non-b hepatitis virus antigen peptide
JPH02167081A (ja) 1988-12-21 1990-06-27 Tetsuo Nakamura 非Ａ非Ｂ型肝炎ウイルスゲノムＲＮＡ、ｃＤＮＡおよびウイルス抗原蛋白質
WO1990011089A1 (en) * 1989-03-17 1990-10-04 Chiron Corporation Nanbv diagnostics and vaccines
DK0398748T3 (da) * 1989-05-18 2002-03-18 Chiron Corp NANBV-diagnostika: polynukleotider anvendelige til screening for hepatitis C virus
EP0416725A3 (en) * 1989-07-14 1991-03-20 Chugai Seiyaku Kabushiki Kaisha Blood-borne non-a, non-b hepatitis specific protein, dna encoding it, and process for its production
DK0414475T3 (da) 1989-08-25 1998-02-09 Chiron Corp Fremgangsmåder til dyrkning af HCV i B- eller T-lymfocyt-cellelinier
US5372928A (en) 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
CA2065287C (en) 1989-09-15 1999-12-21 Tatsuo Miyamura New hcv isolates
US5106726A (en) * 1990-02-16 1992-04-21 United Biomedical, Inc. Synthetic peptides specific for the detection of antibodies to HCV
BR9106309A (pt) 1990-04-04 1993-04-20 Chiron Corp Combinacao de antigenos sinteticos de hepatite c viral (hcv),processo de detectar anticorpos para o virus da hepatite c e estojo para realizar teste
EP0464287A1 (en) * 1990-06-25 1992-01-08 The Research Foundation for Microbial Diseases of Osaka University Non-A, non-B hepatitis virus genomic cDNA and antigen polypeptide

Also Published As

Publication number Publication date
DE4040339C2 (de) 1999-07-08
FI906208A (fi) 1991-06-19
BR9006422A (pt) 1991-09-24
IT9048588A0 (it) 1990-12-17
FI906208A0 (fi) 1990-12-17
JPH06107687A (ja) 1994-04-19
IE904540A1 (en) 1991-06-19
SE9004010L (sv) 1991-06-19
CH684594A5 (fr) 1994-10-31
SE9004010A (sv) 1991-06-19
DK298190D0 (da) 1990-12-17
IT9048588A1 (it) 1991-06-19
FR2655990B1 (sv) 1995-04-07
AU642942B2 (en) 1993-11-04
NO905438D0 (no) 1990-12-17
US6210675B1 (en) 2001-04-03
DK298190A (da) 1991-06-19
CA2032381A1 (en) 1991-06-19
NZ236491A (en) 1993-10-26
AT400724B (de) 1996-03-25
NL9002779A (nl) 1991-07-16
AR243239A1 (es) 1993-07-30
GB9027250D0 (en) 1991-02-06
BE1005485A5 (fr) 1993-08-10
CA2032381C (en) 2006-02-21
GB2239245B (en) 1993-11-10
NO905438L (no) 1991-06-19
FR2655990A1 (fr) 1991-06-21
HUT56883A (en) 1991-10-28
AU6817590A (en) 1991-06-20
IE65172B1 (en) 1995-10-04
GB2239245A (en) 1991-06-26
HU908296D0 (en) 1991-06-28
GR1001261B (el) 1993-06-30
GR900100868A (en) 1992-05-12
DE4040339A1 (de) 1991-06-20
ES2029171A6 (es) 1992-07-16
IT1242183B (it) 1994-02-16
ATA257190A (de) 1995-07-15
LU87861A1 (fr) 1991-10-08

Similar Documents

Publication Publication Date Title
SE9004010D0 (sv) Viralt medel
ATE195953T1 (de) Peptide zur induktion von immunantwort durch zytotoxischen t lymphocyten gegen das virus von hepatitis c
GB2255777B (en) Indicator cells and recombinant retroviruses for use in the detection of gene sequences
DK0770679T3 (da) HCV-specifikke peptider, præparater indeholdende dem og anvendelse deraf
DE69334357D1 (de) Nachweis und Typisierung das Hepatitis C Virus (HCV) mittels 5'UTR und NS5 Nukleinsäuresequenzen
FI946066A0 (sv) Nya sekvenser av genotyperna av hepatit-C-virus och användning av dessa som terapeutiska och diagnostiska medel
DK0677114T3 (da) Rekombinant svinekoppevirus
KR960701988A (ko) 세포내 감염원에 감염된 개체의 치료방법 및 치료물질(methods and materials for treatment of individuals infected with intracellular in-fectious agents)
ATE229543T1 (de) Polypeptide des hepatitis c-virus (hiv)
DK1278534T3 (da) Fremgangsmåder og sammensætninger til svækkelse af multiplikationen af HIV-1
ATE309367T1 (de) Nukleotid- und aminosäuresequenzen der gene des hüllproteins 1 und des kernproteins von hepatitis c virus
GR3029264T3 (en) Anti-feline immunodeficiency virus (fiv) vaccines.
WO2001021807A8 (en) Hepatitis c virus envelope two protein (e2) which lacks all or part of the hypervariable region one (hvr1), corresponding nucleic acids, chimeric viruses and uses thereof
IL87391A0 (en) Hiv proteins and peptides,dna coding therefor,vectors comprising such dna,the use of the proteins and peptides in diagnosis of aids and vaccine compositions containing them
KR890700030A (ko) 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법
DK35891A (da) Praktisk taget rent, antigenisk peptid eller protein med en epitop af haemophilus influenzae, dets fremstilling og anvendelse
IL75553A (en) Dna sequence coding for a cholinesterase-like peptide, peptides produced by cells containing said dna and antibodies thereto
DE69106141D1 (de) Non-a non-b sequenzen.
DE68918399D1 (de) Lymphokine, DNS-Sequenzen, die diese Lymphokine kodieren, und sie enthaltende pharmazeutische Zusammensetzungen.
JPS642581A (en) Dna capable of coding rinderpest virus antigenic protein
IT1270941B (it) Peptidi di hcv e loro usi.
AR036104A1 (es) Un receptor acoplado a la proteina g, gave3

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9004010-6